Prescription drug · NDA
Zegalogue (Dasiglucagon) NDC 0169-1912
Dasiglucagon .6 mg/.6mL · Injection, Solution · Subcutaneous · Novo Nordisk
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0169-1912-01 | 00169191201 | 1 CONTAINER in 1 PACKAGE (0169-1912-01) / 1 SYRINGE, GLASS in 1 CONTAINER / .6 mL in 1 SYRINGE, GLASSMarketed from Jun 26, 2023 | |
| 0169-1912-02 | 00169191202 | 2 PACKAGE in 1 CARTON (0169-1912-02) / 1 CONTAINER in 1 PACKAGE (0169-1912-12) / 1 SYRINGE, GLASS in 1 CONTAINER / .6 mL in 1 SYRINGE, GLASSMarketed from Jun 26, 2023 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Zegalogue
- Generic name (nonproprietary)
- dasiglucagon
- Active ingredients
- Dasiglucagon — .6 mg/.6mL
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Labeler
- Novo NordiskNDC labeler code 0169
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 214231
- Marketing start
- Marketing end
- Other FDA classes
- Glucagon Receptor Agonists (Mechanism)Increased Glycogenolysis (Physiologic effect)
- Identifiers
- Product ID 0169-1912_df9fed8a-f13a-4ef4-90cc-8ba51909d30cSPL ID df9fed8a-f13a-4ef4-90cc-8ba51909d30cSPL set ID 14704879-872c-4967-8779-04a3bbdfb4e6RxCUI 2535238, 2535243, 2535247, 2535249UNII AD4J2O47FQ
- Pharmacologic class
- Antihypoglycemic Agent
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N400169191201followed by a unit qualifier and the quantityPackage 00169-1912-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
ZEGALOGUE ® is indicated for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes aged 6 years and above. ZEGALOGUE is an antihypoglycemic agent indicated for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes aged 6 years and above. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 0169-1912
- What is NDC 0169-1912?
- 0169-1912 is the product NDC for Zegalogue (dasiglucagon), Dasiglucagon .6 mg/.6mL injection, solution, listed with the FDA by Novo Nordisk. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Zegalogue (Dasiglucagon).
- What is the active ingredient?
- Dasiglucagon.
- Who is the labeler?
- Novo Nordisk, NDC labeler code 0169. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Zegalogue?
- 1 other product NDC are listed under this name. See all Zegalogue NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Zegalogue products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Zegaloguedasiglucagon | Dasiglucagon .6 mg/.6mL | Injection, SolutionSubcutaneous | Novo Nordisk | 0169-1913 | 00169-1913-0100169-1913-02 |
Other NDCs under NDA 214231
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Zegaloguedasiglucagon | Dasiglucagon .6 mg/.6mL | Injection, SolutionSubcutaneous | Novo Nordisk | 0169-1913 |